Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haemophilia : the official journal of the World Federation of Hemophilia 2023-01, Vol.29 (1), p.404-407
Hauptverfasser:	Sidonio, Robert F., Casiano, Sandra, Falk, Aletta, Altincatal, Arman, Katragadda, Suresh, Santagostino, Elena, Windyga, Jerzy
Format:	Artikel
Sprache:	eng
Schlagworte:	clinical study Coagulation factors factor IX Factor IX - pharmacokinetics Factor IX - therapeutic use factor IX Fc fusion protein Fc receptors Fusion protein haemophilia B Hemophilia B - drug therapy Humans Immunoglobulin Fc Fragments - therapeutic use Pharmacokinetics Recombinant Fusion Proteins - pharmacokinetics Recombinant Fusion Proteins - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!